|
USA-UT-LANCASTER Κατάλογοι Εταιρεία
|
Εταιρικά Νέα :
- What is STIVARGA ® (regorafenib)? - Stivarga US Patient Oct13
STIVARGA is a once-daily, prescription anticancer medicine for patients who have received previous treatment with certain chemotherapy medicines to treat colon cancer (CRC) that has now spread to other parts of the body
- STIVARGA® (regorafenib) | Patient Website
CRC that has spread to other parts of the body and for which they have received previous treatment with certain chemotherapy medicines STIVARGA in mCRC GIST STIVARGA for gastrointestinal stromal tumor (GIST) A rare stomach, bowel, or esophagus cancer that cannot be treated with surgery or that has spread to other parts of the body and for
- Starting Treatment | STIVARGA® (regorafenib) Patient Website
plan to have surgery or have had a recent surgery You should stop taking STIVARGA at least 2 weeks before planned surgery; are pregnant or plan to become pregnant STIVARGA can harm your unborn baby Females and males should use effective birth control during treatment with STIVARGA and for 2 months after their last dose of STIVARGA
- Managing side effects - Stivarga US Patient Oct13
Recommendations for managing the side effects of STIVARGA® (regorafenib) Visit STIVARGA-US com to see full safety and Prescribing Information, including Boxed Warning cancer that has spread to other parts of the body and for which they have received previous treatment with certain chemotherapy medicines;
- Taking STIVARGA ® (regorafenib) - Stivarga US Patient Oct13
Do: Always keep STIVARGA tightly closed in its original bottle as it contains a special drying agent (called a desiccant) to keep your medicine dry; Remove the drying agent to get tablets from the bottle Always put it back in the bottle after getting your medicine; Always keep the bottle of STIVARGA tightly closed and store at room temperature (68°-77° F) in cases where the weather can
- Side Effects | STIVARGA® (regorafenib) | Patient Website
Learn more about the side effects of STIVARGA® (regorafenib) Visit STIVARGA-US com to see full safety and Prescribing Information, including Boxed Warning cancer that has spread to other parts of the body and for which they have received previous treatment with certain chemotherapy medicines;
- Questions To Ask Your Doctor About STIVARGA - Stivarga US Patient Oct13
Wounds may not heal properly during STIVARGA treatment Tell your healthcare provider if you plan to have any surgery before starting or during treatment with STIVARGA You should stop taking STIVARGA at least 2 weeks before planned surgery Your healthcare provider should tell you when you may start taking STIVARGA again after surgery
- Access Services by Bayer™ | STIVARGA® (regorafenib) Patient Website
Visit STIVARGA-US com for more information and full safety and Prescribing Information, including Boxed Warning Learn about Access Services by Bayer This free program is here to support you and your caregivers cancer that has spread to other parts of the body and for which they have received previous treatment with certain chemotherapy
- Support Resources | STIVARGA® (regorafenib) Patient Website
plan to have surgery or have had a recent surgery You should stop taking STIVARGA at least 2 weeks before planned surgery; are pregnant or plan to become pregnant STIVARGA can harm your unborn baby Females and males should use effective birth control during treatment with STIVARGA and for 2 months after their last dose of STIVARGA
- Co-Pay Program | STIVARGA® (regorafenib) Patient Website
plan to have surgery or have had a recent surgery You should stop taking STIVARGA at least 2 weeks before planned surgery; are pregnant or plan to become pregnant STIVARGA can harm your unborn baby Females and males should use effective birth control during treatment with STIVARGA and for 2 months after their last dose of STIVARGA
|
|